{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:24:18Z","timestamp":1791350658894,"version":"4.3.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"27","license":[{"start":{"date-parts":[[2011,2,21]],"date-time":"2011-02-21T00:00:00Z","timestamp":1298246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,2,21]],"date-time":"2011-02-21T00:00:00Z","timestamp":1298246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2011,7,7]]},"DOI":"10.1038\/onc.2011.21","type":"journal-article","created":{"date-parts":[[2011,2,21]],"date-time":"2011-02-21T18:49:41Z","timestamp":1298314181000},"page":"3024-3035","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents"],"prefix":"10.1038","volume":"30","author":[{"given":"D","family":"Palmieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"De Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Postiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Pacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C M","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,21]]},"reference":[{"key":"BFonc201121_CR1","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nature01368","volume":"421","author":"CJ Bakkenist","year":"2003","unstructured":"Bakkenist CJ, Kastan MB . (2003). DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421: 499\u2013506.","journal-title":"Nature"},{"key":"BFonc201121_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/sj.onc.1206144","volume":"22","author":"E Berkovich","year":"2003","unstructured":"Berkovich E, Ginsberg D . (2003). ATM is a target for positive regulation by E2F-1. Oncogene 22: 161\u2013167.","journal-title":"Oncogene"},{"key":"BFonc201121_CR3","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1038\/sj.onc.1205368","volume":"21","author":"MT Berlingieri","year":"2002","unstructured":"Berlingieri MT, Pierantoni GM, Giancotti V, Santoro M, Fusco A . (2002). Thyroid cell transformation requires the expression of the HMGA1 proteins. Oncogene 21: 2971\u20132980.","journal-title":"Oncogene"},{"key":"BFonc201121_CR4","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1126\/science.281.5383.1677","volume":"281","author":"CE Canman","year":"1998","unstructured":"Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K et al. (1998). Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677\u20131679.","journal-title":"Science"},{"key":"BFonc201121_CR5","first-page":"2439","volume":"13","author":"G Chiappetta","year":"1996","unstructured":"Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F et al. (1996). High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13: 2439\u20132446.","journal-title":"Oncogene"},{"key":"BFonc201121_CR6","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1158\/1078-0432.CCR-07-4298","volume":"14","author":"E Crescenzi","year":"2008","unstructured":"Crescenzi E, Palumbo G, de Boer J, Brady HJ . (2008). Ataxia telangiectasia mutated and p21CIP1 modulate cell survival of drug-induced senescent tumor cells: implications for chemotherapy. Clin Cancer Res 14: 1877\u20131887.","journal-title":"Clin Cancer Res"},{"key":"BFonc201121_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrc2440","volume":"8","author":"F d'Adda di Fagagna","year":"2008","unstructured":"d'Adda di Fagagna F . (2008). Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 8: 512\u2013522.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201121_CR8","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/carcin\/22.10.1583","volume":"22","author":"M Fedele","year":"2001","unstructured":"Fedele M, Battista S, Manfioletti G, Croce CM, Giancotti V, Fusco A . (2001a). Role of the high mobility group A proteins in human lipomas. Carcinogenesis 22: 1583\u20131591.","journal-title":"Carcinogenesis"},{"key":"BFonc201121_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbagrm.2009.11.007","volume":"1799","author":"M Fedele","year":"2010","unstructured":"Fedele M, Fusco A . (2010). HMGA and cancer. Biochim Biophys Acta 1799: 48\u201354.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc201121_CR10","first-page":"4583","volume":"61","author":"M Fedele","year":"2001","unstructured":"Fedele M, Pierantoni GM, Berlingieri MT, Battista S, Baldassarre G, Munshi N et al. (2001b). Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells. Cancer Res 61: 4583\u20134590.","journal-title":"Cancer Res"},{"key":"BFonc201121_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ccr.2006.04.024","volume":"9","author":"M Fedele","year":"2006","unstructured":"Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S et al. (2006). HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 9: 459\u2013471.","journal-title":"Cancer Cell"},{"key":"BFonc201121_CR12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nrc2271","volume":"7","author":"A Fusco","year":"2007","unstructured":"Fusco A, Fedele M . (2007). Roles of HMGA proteins in cancer. Nat Rev Cancer 7: 899\u2013910.","journal-title":"Nat Rev Cancer"},{"key":"BFonc201121_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/gcc.10261","volume":"38","author":"N Gueven","year":"2003","unstructured":"Gueven N, Keating K, Fukao T, Loeffler H, Kondo N, Rodemann HP et al. (2003). Site-directed mutagenesis of the ATM promoter: consequences for response to proliferation and ionizing radiation. Genes Chromosomes Cancer 38: 157\u2013167.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFonc201121_CR14","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1158\/0008-5472.CAN-04-2727","volume":"64","author":"I Hickson","year":"2004","unstructured":"Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI et al. (2004). Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 64: 9152\u20139159.","journal-title":"Cancer Res"},{"key":"BFonc201121_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1042\/BST0370483","volume":"37","author":"SP Jackson","year":"2009","unstructured":"Jackson SP . (2009). The DNA-damage response: new molecular insights and new approaches to cancer therapy. Biochem Soc Trans 37: 483\u2013494.","journal-title":"Biochem Soc Trans"},{"key":"BFonc201121_CR16","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1128\/MCB.9.5.2114","volume":"9","author":"KR Johnson","year":"1989","unstructured":"Johnson KR, Lehn DA, Reeves R . (1989). Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol Cell Biol 9: 2114\u20132123.","journal-title":"Mol Cell Biol"},{"key":"BFonc201121_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1158\/0008-5472.CAN-03-2384","volume":"64","author":"M K\u00fchne","year":"2004","unstructured":"K\u00fchne M, Riballo E, Rief N, Rothkamm K, Jeggo PA, L\u00f6brich MA . (2004). Double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity. Cancer Res 64: 500\u2013508.","journal-title":"Cancer Res"},{"key":"BFonc201121_CR18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrm2514","volume":"9","author":"MF Lavin","year":"2008","unstructured":"Lavin MF . (2008). Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 9: 759\u2013769.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc201121_CR19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.4161\/cc.6.8.4180","volume":"6","author":"MF Lavin","year":"2007","unstructured":"Lavin MF, Kozlov S . (2007). ATM activation. DNA damage response. Cell Cycle 6: 931\u2013942.","journal-title":"Cell Cycle"},{"key":"BFonc201121_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD . (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402\u2013408.","journal-title":"Methods"},{"key":"BFonc201121_CR21","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.1158\/0008-5472.CAN-04-1410","volume":"64","author":"J Martinez Hoyos","year":"2004","unstructured":"Martinez Hoyos J, Fedele M, Battista S, Pentimalli F, Kruhoffer M, Arra C et al. (2004). Identification of the genes up- and down-regulated by the high mobility group A1 (HMGA1) proteins: tissue specificity of the HMGA1-dependent gene regulation. Cancer Res 64: 5728\u20135735.","journal-title":"Cancer Res"},{"key":"BFonc201121_CR22","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1080\/09553009414551971","volume":"66","author":"MS Meyn","year":"1994","unstructured":"Meyn MS, Strasfeld L, Allen C . (1994). Testing the role of p53 in the expression of genetic instability and apoptosis in ataxia-telangiectasia. Int J Radiat Biol 66: S141\u2013S149.","journal-title":"Int J Radiat Biol"},{"key":"BFonc201121_CR23","doi-asserted-by":"publisher","first-page":"22563","DOI":"10.1074\/jbc.274.32.22563","volume":"274","author":"S Nagpal","year":"1999","unstructured":"Nagpal S, Ghosn C, DiSepio D, Molina Y, Sutter M, Klein ES et al. (1999). Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor. J Biol Chem 274: 22563\u201322568.","journal-title":"J Biol Chem"},{"key":"BFonc201121_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.cell.2006.05.052","volume":"126","author":"M Narita","year":"2006","unstructured":"Narita M, Narita M, Krizhanovsky V, Nu\u00f1ez S, Chicas A, Hearn SA et al. (2006). A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 126: 503\u2013514.","journal-title":"Cell"},{"key":"BFonc201121_CR25","doi-asserted-by":"publisher","first-page":"22719","DOI":"10.1074\/jbc.M001002200","volume":"275","author":"T O'Neill","year":"2000","unstructured":"O'Neill T, Dwyer AJ, Ziv Y, Chan DW, Lees-Miller SP, Abraham RH et al. (2000). Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J Biol Chem 275: 22719\u201322727.","journal-title":"J Biol Chem"},{"key":"BFonc201121_CR26","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ncb1024","volume":"5","author":"S Parrinello","year":"2003","unstructured":"Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S, Campisi J . (2003). Oxygen sensitivity severely limits the replicative lifespan of murine fibroblasts. Nat Cell Biol 5: 741\u2013747.","journal-title":"Nat Cell Biol"},{"key":"BFonc201121_CR27","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1016\/j.ejca.2008.07.033","volume":"44","author":"F Pentimalli","year":"2008","unstructured":"Pentimalli F, Palmieri D, Pacelli R, Garbi C, Cesari R, Martin E et al. (2008). HMGA1 protein is a novel target of the ATM kinase. Eur J Cancer 44: 2668\u20132679.","journal-title":"Eur J Cancer"},{"key":"BFonc201121_CR28","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.1038\/sj.onc.1204635","volume":"20","author":"GM Pierantoni","year":"2001","unstructured":"Pierantoni GM, Fedele M, Pentimalli F, Benvenuto G, Pero R, Viglietto G et al. (2001). High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene 20: 6132\u20136141.","journal-title":"Oncogene"},{"key":"BFonc201121_CR29","first-page":"2045","volume":"5","author":"GM Pierantoni","year":"2006","unstructured":"Pierantoni GM, Rinaldo C, Esposito F, Mottolese M, Soddu S, Fusco A . (2006). High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ 5: 2045\u20132048.","journal-title":"Cell Death Differ"},{"key":"BFonc201121_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1172\/JCI29852","volume":"117","author":"GM Pierantoni","year":"2007","unstructured":"Pierantoni GM, Rinaldo C, Mottolese M, Di Benedetto A, Esposito F, Soddu S et al. (2007). High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J Clin Invest 117: 693\u2013702.","journal-title":"J Clin Invest"},{"key":"BFonc201121_CR31","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.dnarep.2005.04.010","volume":"8","author":"R Reeves","year":"2005","unstructured":"Reeves R, Adair JE . (2005). Role of high mobility group (HMG) chromatin proteins in DNA repair. DNA Repair (Amst) 8: 926\u2013938.","journal-title":"DNA Repair (Amst)"},{"key":"BFonc201121_CR32","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1016\/S0021-9258(19)38926-4","volume":"265","author":"R Reeves","year":"1990","unstructured":"Reeves R, Nissen MS . (1990). The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J Biol Chem 265: 8573\u20138582.","journal-title":"J Biol Chem"},{"key":"BFonc201121_CR33","first-page":"4375","volume":"59","author":"JN Sarkaria","year":"1999","unstructured":"Sarkaria JN, Busby EC, Tibbetts RS, Roos P, Taya Y, Karnitz LM et al. (1999). Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res 59: 4375\u20134382.","journal-title":"Cancer Res"},{"key":"BFonc201121_CR34","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1053\/srao.2001.26030","volume":"11","author":"JN Sarkaria","year":"2001","unstructured":"Sarkaria JN, Eshleman JS . (2001). ATM as a target for novel radiosensitizers. Semin Radiat Oncol 11: 316\u2013327.","journal-title":"Semin Radiat Oncol"},{"key":"BFonc201121_CR35","first-page":"4375","volume":"58","author":"JN Sarkaria","year":"1998","unstructured":"Sarkaria JN, Tibbetts RS, Busby EC, Kennedy AP, Hill DE, Abraham RT . (1998). Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. Cancer Res 58: 4375\u20134382.","journal-title":"Cancer Res"},{"key":"BFonc201121_CR36","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1126\/science.7792600","volume":"268","author":"K Savitsky","year":"1995","unstructured":"Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L et al. (1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749\u20131753.","journal-title":"Science"},{"key":"BFonc201121_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nature07618","volume":"457","author":"A Viale","year":"2009","unstructured":"Viale A, De Franco F, Orleth A, Cambiaghi V, Giuliani V, Bossi D et al. (2009). Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 457: 51\u201356.","journal-title":"Nature"},{"key":"BFonc201121_CR38","first-page":"4256","volume":"60","author":"LJ Wood","year":"2000","unstructured":"Wood LJ, Maher JF, Bunton TE, Resar LM . (2000). The oncogenic properties of the HMG-I gene family. Cancer Res 60: 4256\u20134261.","journal-title":"Cancer Res"},{"key":"BFonc201121_CR39","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1101\/gad.10.19.2411","volume":"10","author":"Y Xu","year":"1996","unstructured":"Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D . (1996). Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev 10: 2411\u20132422.","journal-title":"Genes Dev"},{"key":"BFonc201121_CR40","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1128\/MCB.18.7.4385","volume":"18","author":"Y Xu","year":"1998","unstructured":"Xu Y, Yang EM, Brugarolas J, Jacks T, Baltimore D . (1998). Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm\u2212\/\u2212 mice. Mol Cell Biol 18: 4385\u20134390.","journal-title":"Mol Cell Biol"},{"key":"BFonc201121_CR41","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/376771a0","volume":"376","author":"X Zhou","year":"1995","unstructured":"Zhou X, Benson KF, Ashar HR, Chada K . (1995). Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376: 771\u2013774.","journal-title":"Nature"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201121","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201121.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:17:27Z","timestamp":1647886647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,21]]},"references-count":41,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2011,7,7]]}},"alternative-id":["BFonc201121"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.21","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,21]]},"assertion":[{"value":"23 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}